Global Thyroid Gland Disorder Market Trends, Size, Share, Forecast - 2019-2025
Global Thyroid gland disorder treatment market is likely to grow at a significant pace over the forecast period. Factors augmenting the market growth are rising prevalence of thyroid disorders such as hyperthyroidism and hypothyroidism across the globe. According to the American Thyroid Association, in 2017, an estimated 20 million Americans have some form of thyroid disease. Moreover, more than 12% of the US population will develop thyroid disorder during their lifespan. This increasing prevalence of thyroid disorders is likely to augment the demand for treatment to cure thyroid gland disorders; thereby, fueling the market growth over the forecast period.
Request a free sample of our report on Global Thyroid Gland Disorder Market: https://www.omrglobal.com/request-sample/thyroid-gland-disorder-treatment-market
Thyroid gland disorder treatment market is segmented on the basis of disorder type, route of administration, and region. On the basis of disorder type, the market has been further segmented into hyperthyroidism, hypothyroidism, and thyroid cancer. Moreover, as per the route of administration, the market is diversified as oral, parental, and others. Additionally, the report analyzes the geographic area which covers this market includes North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to be the dominating market for thyroid gland disorder treatment market over the forecast period. However, Asia-Pacific region is expected to register the highest growth than any other regions across the globe.
A full report of Global Thyroid Gland Disorder Market Is available at https://www.omrglobal.com/industry-reports/thyroid-gland-disorder-treatment-market
Global Thyroid Gland Disorder Treatment Market Segmentation
By Type
Hyperthyroidism
Hypothyroidism
Thyroid Cancer
By Route of Administration
Oral
Parenteral
Others
Regional Analysis
North America
United States
Canada
Europe
UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Company Profiles
Abbott Laboratories Inc.
AbbVie, Inc.
Acella Pharmaceutical LLC
Allergan PLC
Amgen, Inc.
Apitope International NV
Aspen Pharmacare Holdings Ltd.
AstraZeneca PLC
Bayer AG
Epivax, Inc.
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/thyroid-gland-disorder-treatment-market
About Us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
Global Thyroid gland disorder treatment market is likely to grow at a significant pace over the forecast period. Factors augmenting the market growth are rising prevalence of thyroid disorders such as hyperthyroidism and hypothyroidism across the globe. According to the American Thyroid Association, in 2017, an estimated 20 million Americans have some form of thyroid disease.
